BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1047 related articles for article (PubMed ID: 22284969)

  • 1. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
    Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF
    Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
    Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
    Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
    Chromecki TF; Cha EK; Fajkovic H; Margulis V; Novara G; Scherr DS; Lotan Y; Raman JD; Kassouf W; Bensalah K; Weizer A; Kikuchi E; Roscigno M; Remzi M; Matsumoto K; Walton TJ; Pycha A; Ficarra V; Karakiewicz PI; Zigeuner R; Pummer K; Shariat SF
    Eur Urol; 2012 Feb; 61(2):245-53. PubMed ID: 21975249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.
    Capitanio U; Shariat SF; Isbarn H; Weizer A; Remzi M; Roscigno M; Kikuchi E; Raman JD; Bolenz C; Bensalah K; Koppie TM; Kassouf W; Fernández MI; Ströbel P; Wheat J; Zigeuner R; Langner C; Waldert M; Oya M; Guo CC; Ng C; Montorsi F; Wood CG; Margulis V; Karakiewicz PI
    Eur Urol; 2009 Jul; 56(1):1-9. PubMed ID: 19361911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.
    Bagrodia A; Kuehhas FE; Gayed BA; Wood CG; Raman JD; Kapur P; Derweesh IH; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Margulis V
    Urology; 2013 May; 81(5):972-7. PubMed ID: 23523292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
    BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival.
    Colin P; Ouzzane A; Yates DR; Audenet F; Pignot G; Arvin-Berod A; Merigot de Treigny O; Laurent G; Valeri A; Irani J; Saint F; Gardic S; Gres P; Rozet F; Neuzillet Y; Ruffion A; Rouprêt M
    Ann Surg Oncol; 2012 Oct; 19(11):3613-20. PubMed ID: 22843187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
    J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.
    Zigeuner R; Shariat SF; Margulis V; Karakiewicz PI; Roscigno M; Weizer A; Kikuchi E; Remzi M; Raman JD; Bolenz C; Bensalah K; Capitanio U; Koppie TM; Kassouf W; Sircar K; Patard JJ; Fernández MI; Wood CG; Montorsi F; Ströbel P; Wheat JC; Haitel A; Oya M; Guo CC; Ng C; Chade DC; Sagalowsky A; Langner C
    Eur Urol; 2010 Apr; 57(4):575-81. PubMed ID: 19959276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.
    Kuroda K; Asakuma J; Horiguchi A; Tasaki S; Yoshii H; Sato A; Ito K; Seguchi K; Sumitomo M; Asano T
    Urol Int; 2012; 88(2):225-31. PubMed ID: 22236640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter.
    Dalpiaz O; Ehrlich G; Quehenberger F; Pummer K; Zigeuner R
    Urol Oncol; 2014 Jan; 32(1):34.e1-8. PubMed ID: 23506964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.
    Espiritu PN; Sverrisson EF; Sexton WJ; Pow-Sang JM; Poch MA; Dhillon J; Spiess PE
    Urol Oncol; 2014 Jul; 32(5):619-24. PubMed ID: 24495448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.
    Ouzzane A; Colin P; Xylinas E; Pignot G; Ariane MM; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M;
    Eur Urol; 2011 Dec; 60(6):1258-65. PubMed ID: 21665356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
    Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
    Wheat JC; Weizer AZ; Wolf JS; Lotan Y; Remzi M; Margulis V; Wood CG; Montorsi F; Roscigno M; Kikuchi E; Zigeuner R; Langner C; Bolenz C; Koppie TM; Raman JD; Fernández M; Karakiewizc P; Capitanio U; Bensalah K; Patard JJ; Shariat SF
    Urol Oncol; 2012; 30(3):252-8. PubMed ID: 20451416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.
    Fajkovic H; Cha EK; Jeldres C; Donner G; Chromecki TF; Margulis V; Novara G; Lotan Y; Raman JD; Kassouf W; Seitz C; Bensalah K; Weizer A; Kikuchi E; Roscigno M; Remzi M; Matsumoto K; Breinl E; Pycha A; Ficarra V; Montorsi F; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Mar; 187(3):845-51. PubMed ID: 22248522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.